The Effect of Quizartinib on the Resistance of Acute Myeloid Leukemia Cells with FLT3-ITD-Positive and FLT3-ITD-Negative Phenotypes to DNA Topoisomerase Inhibitors
Abstract— Intragenic tandem duplications in the FLT3 gene (FLT3-ITD) are one of the most common genetic abnormalities in acute myeloid leukemia (AML) and are associated with a poor prognosis, which has led to the introduction of new-generation FLT3 inhibitors, including quizartinib, into clinical practice as part of combination therapy regimens. Given the heterogeneity of the clonal composition of AML in terms of the proportion of FLT3-ITD-positive (FLT3-ITD(+)) and FLT3-ITD-negative (FLT3-ITD(–)) clones, the effect of FLT3 inhibition on the sensitivity of various leukemic cell subpopulations to DNA-damaging chemotherapeutic agents remains poorly understood. This study demonstrates that pretreatment of FLT3-ITD(–) THP-1 AML cells with quizaritinib at non-toxic concentrations increases their resistance to the cytotoxic effects of etoposide and topotecan, whereas no such protective effect is observed in FLT3-ITD(+) MV4-11 cells. The results obtained in this study suggest that quizaritinib, as part of combination chemotherapy, may contribute to the development of drug resistance in FLT3-ITD(–) AML subclones to DNA-damaging agents by arresting proliferation in the late G2/M phase and shifting the balance of pro- and anti-apoptotic proteins of the Bcl-2 family toward survival, a factor that must be taken into account when developing targeted therapy regimens with FLT3 inhibitors.
Authors
- А. С. Сенотов (ORCID: https://orcid.org/0000-0003-1607-0057)
- Ya. V. Lomovskaya
- K. S. Krasnov (ORCID: https://orcid.org/0000-0001-8764-691X)
- Р. С. Фадеев (ORCID: https://orcid.org/0000-0001-8877-6724)
- Irina V Odinokova (ORCID: https://orcid.org/0000-0002-6331-0191)
- A. I. Zvyagina (ORCID: https://orcid.org/0000-0002-6373-2079)
- M. I. Kobyakova (ORCID: https://orcid.org/0000-0002-6846-9994)
- A. S. Didenko
- E. I. Mescheryakova
Institutions
- Russian Academy of Sciences (RU)
- Lomonosov Moscow State University (RU)
- Institute of Theoretical and Experimental Biophysics (RU)
- Institute of Cell Biophysics (RU)
Publication Details
- Journal
- Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1134/s1990747826700273
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Russian Academy of Sciences